Angelini Ventures
Scaling mental health innovation: Angelini Ventures backs Serenis' mission for accessible wellbeing
Angelini Ventures has led a €12 million follow-on investment in Serenis, a pioneering digital health platform transforming access to mental and physical wellbeing services. Co-led by CDP Venture Capital, this round accelerates Serenis' rapid growth trajectory: the company has built a network of over 2,500 licensed professionals, supported more than 170,000 people through 1.5 million completed therapy sessions, and scaled to serve over 250 corporate clients including Nestlé, Satispay, and Leroy Merlin.
With revenues growing from €2M in 2022 to €25M in 2024, and a projected run-rate exceeding €40M in 2025, Serenis demonstrates the substantial demand for accessible, technology-enabled mental health solutions.
Founded in 2021, Serenis combines proprietary digital technology with a hybrid model of qualified therapists to tackle accessibility barriers and stigma surrounding mental health care. The investment will strengthen the company's digital infrastructure, enhance clinical capabilities, and expand its corporate wellbeing programs to reach hundreds of thousands more employees.
We are proud to have believed in Serenis since its early steps and to accompany its growth today as lead investor. Investing in Serenis means believing that mental and physical wellbeing should be accessible to everyone. At Angelini Ventures, we are honored to support a team that, with clinical rigor and innovation, is building an accessible and sustainable model of digital and in-person care, set to become a benchmark in Italy.
Elia Stupka,
This investment reinforces Angelini Ventures' strategic focus on mental and brain health as core priorities within its BioTech and HealthTech portfolio, advancing technology-enabled solutions that address some of today's most pressing healthcare challenges.